开云app官网登录入口网页版-官方正版

#奥贝胆酸#

11篇内容 | 1090人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2162696, encodeId=beb5216269646, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>作为<a href='/topic/show?id=3a9f106963cf' target=_blank style='color:#2F92EE;'>#低磷脂相关胆石症#</a>综合征的二线治疗药物。<a href='/topic/show?id=37da8349471' target=_blank style='color:#2F92EE;'>#胆石症#</a>, objectTitle=APT：奥贝胆酸作为低磷脂相关胆石症综合征的二线治疗药物, objectType=article, longId=796017, objectId=0b49e960176e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=0b49e960176e, replyNumber=0, likeNumber=82, createdTime=2023-10-14, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=0b49e960176e, moduleTitle=APT：奥贝胆酸作为低磷脂相关胆石症综合征的二线治疗药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0b49e960176e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471222, encodeId=625e14e122248, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=J Hepatol:奥贝胆酸促进原发性胆汁性肝硬化患者的肝胆汁酸排泄, objectType=article, longId=199326, objectId=780319932660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780319932660, replyNumber=0, likeNumber=73, createdTime=2020-08-14, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780319932660, moduleTitle=J Hepatol:奥贝胆酸促进原发性胆汁性肝硬化患者的肝胆汁酸排泄, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=780319932660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471221, encodeId=576314e1221ba, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Clin Gastroenterology H：长期奥贝胆酸治疗可改善原发性胆源性胆管炎患者的组织学终点 , objectType=article, longId=193332, objectId=b9e7193332c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9e7193332c3, replyNumber=0, likeNumber=101, createdTime=2020-05-03, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9e7193332c3, moduleTitle=Clin Gastroenterology H：长期奥贝胆酸治疗可改善原发性胆源性胆管炎患者的组织学终点 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b9e7193332c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471220, encodeId=96fc14e122040, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响, objectType=article, longId=185404, objectId=6f5918540456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5918540456, replyNumber=0, likeNumber=70, createdTime=2019-12-31, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5918540456, moduleTitle=J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6f5918540456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471219, encodeId=741814e1219fd, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功, objectType=article, longId=184494, objectId=2df618449455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df618449455, replyNumber=0, likeNumber=80, createdTime=2019-12-11, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df618449455, moduleTitle=Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2df618449455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471218, encodeId=d75314e12182e, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Intercept向美国FDA提交奥贝胆酸治疗NASH的新药申请, objectType=article, longId=180297, objectId=fff018029e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fff018029e6c, replyNumber=0, likeNumber=70, createdTime=2019-10-01, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fff018029e6c, moduleTitle=Intercept向美国FDA提交奥贝胆酸治疗NASH的新药申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fff018029e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471217, encodeId=b8a514e121719, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Lancet Gastroen Hepatol：奥贝胆酸治疗熊去氧胆酸无效的原发性胆管炎患者的长期疗效及安全性研究, objectType=article, longId=163045, objectId=cea1163045a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea1163045a2, replyNumber=0, likeNumber=64, createdTime=2019-03-28, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea1163045a2, moduleTitle=Lancet Gastroen Hepatol：奥贝胆酸治疗熊去氧胆酸无效的原发性胆管炎患者的长期疗效及安全性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cea1163045a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471216, encodeId=719b14e121693, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物, objectType=article, longId=160664, objectId=b09616066462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b09616066462, replyNumber=0, likeNumber=65, createdTime=2019-02-22, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b09616066462, moduleTitle=Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b09616066462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471215, encodeId=863714e1215e3, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=NEJM：奥贝胆酸可显著降低原发性胆汁性胆管炎患者碱性磷酸酶及总胆红素的水平, objectType=article, longId=75454, objectId=4b52e545478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b52e545478, replyNumber=0, likeNumber=76, createdTime=2016-08-20, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b52e545478, moduleTitle=NEJM：奥贝胆酸可显著降低原发性胆汁性胆管炎患者碱性磷酸酶及总胆红素的水平, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4b52e545478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471214, encodeId=8a6a14e121482, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Gastroenterology：奥贝胆酸有望成为治疗PBC的新药物, objectType=article, longId=44742, objectId=bf4d44e4244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf4d44e4244, replyNumber=0, likeNumber=68, createdTime=2014-12-28, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf4d44e4244, moduleTitle=Gastroenterology：奥贝胆酸有望成为治疗PBC的新药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bf4d44e4244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1471213, encodeId=7c3214e1213be, content=<a href='/topic/show?id=6f45445e47f' target=_blank style='color:#2F92EE;'>#奥贝胆酸#</a>, objectTitle=Lancet：奥贝胆酸对改善非酒精性脂肪性肝炎有重要作用, objectType=article, longId=42501, objectId=3ccd42501de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ccd42501de, replyNumber=0, likeNumber=55, createdTime=2014-11-14, rootId=0, userName=风铃823, userId=440b7112735, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ccd42501de, moduleTitle=Lancet：奥贝胆酸对改善非酒精性脂肪性肝炎有重要作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ccd42501de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

奥贝胆酸

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

#奥贝胆酸#作为#低磷脂相关胆石症#综合征的二线治疗药物。#胆石症#

APT：奥贝胆酸作为低磷脂相关胆石症综合征的二线治疗药物

2023-10-14发表于加利福尼亚

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

J Hepatol:奥贝胆酸促进原发性胆汁性肝硬化患者的肝胆汁酸排泄

2020-08-14

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Clin Gastroenterology H：长期奥贝胆酸治疗可改善原发性胆源性胆管炎患者的组织学终点

2020-05-03

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响

2019-12-31

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功

2019-12-11

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Intercept向美国FDA提交奥贝胆酸治疗NASH的新药申请

2019-10-01

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Lancet Gastroen Hepatol：奥贝胆酸治疗熊去氧胆酸无效的原发性胆管炎患者的长期疗效及安全性研究

2019-03-28

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物

2019-02-22

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

NEJM：奥贝胆酸可显著降低原发性胆汁性胆管炎患者碱性磷酸酶及总胆红素的水平

2016-08-20

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Gastroenterology：奥贝胆酸有望成为治疗PBC的新药物

2014-12-28

风铃823 (审核中...)

前往app查看评论内容

#奥贝胆酸#

Lancet：奥贝胆酸对改善非酒精性脂肪性肝炎有重要作用

2014-11-14

科室
- - 订阅+
  - 更多科室
工具
服务